Literature DB >> 35928183

Can collaborative working improve diabetic retinal screening rates in individuals also diagnosed with a severe mental illness?

Zoe S Sherwood1, John Sandford2, Sarita Jacob3.   

Abstract

Aim: We aimed to create a collaborative data sharing project between two NHS trusts to improve attendance and access to diabetic retinopathy screening in individuals with severe mental illness (SMI).
Methods: The eligible patient lists were analysed before and after interventions to assess their effectiveness over two data runs.
Results: Screening attendance rates increased by 31% and 25% in the data runs; a significant number of patients (15%) who were screened required onward referral to hospital eye services. Patient registrations increased from 35% to 86% for previously not registered individuals. Inpatients were around 50% more likely to get screened and registered than community patients.
Conclusion: Information sharing and collaborative working between services can improve patient health outcomes, increasing the number of eligible individuals with SMI registered and improving attendance. The project shows the potential for future data sharing collaborations, highlighting the need for further improvement, development and investment. © Royal College of Physicians 2022 All rights reserved.

Entities:  

Keywords:  collaborative care; diabetes; health inequalities; retinal screening; severe mental illness

Year:  2022        PMID: 35928183      PMCID: PMC9345232          DOI: 10.7861/fhj.2022-0008

Source DB:  PubMed          Journal:  Future Healthc J        ISSN: 2514-6645


  13 in total

Review 1.  Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review.

Authors:  Daniel Shu Wei Ting; Gemmy Chui Ming Cheung; Tien Yin Wong
Journal:  Clin Exp Ophthalmol       Date:  2016-02-17       Impact factor: 4.207

2.  Quality of general medical care among patients with serious mental illness: does colocation of services matter?

Authors:  Amy M Kilbourne; Paul A Pirraglia; Zongshan Lai; Mark S Bauer; Martin P Charns; Devra Greenwald; Deborah E Welsh; John F McCarthy; Elizabeth M Yano
Journal:  Psychiatr Serv       Date:  2011-08       Impact factor: 3.084

3.  Equity of uptake of a diabetic retinopathy screening programme in a geographically and socio-economically diverse population.

Authors:  E Orton; A Forbes-Haley; L Tunbridge; S Cohen
Journal:  Public Health       Date:  2013-08-22       Impact factor: 2.427

4.  "A Touch of Sugar": A Qualitative Study of the Impact of Health Beliefs on Type 1 and Type 2 Diabetes Self-Management Among Black Canadian Adults.

Authors:  Rukia M Swaleh; Catherine Yu
Journal:  Can J Diabetes       Date:  2020-12-14       Impact factor: 4.190

5.  Mortality gap for people with bipolar disorder and schizophrenia: UK-based cohort study 2000-2014.

Authors:  Joseph F Hayes; Louise Marston; Kate Walters; Michael B King; David P J Osborn
Journal:  Br J Psychiatry       Date:  2017-07-06       Impact factor: 9.319

6.  Divergent Perceptions of Barriers to Diabetic Retinopathy Screening Among Patients and Care Providers, Los Angeles, California, 2014-2015.

Authors:  Yang Lu; Lilian Serpas; Pauline Genter; Betty Anderson; David Campa; Eli Ipp
Journal:  Prev Chronic Dis       Date:  2016-10-06       Impact factor: 2.830

7.  System-level and patient-level explanations for non-attendance at diabetic retinopathy screening in Sutton and Merton (London, UK): a qualitative analysis of a service evaluation.

Authors:  R Strutton; A Du Chemin; I M Stratton; A S Forster
Journal:  BMJ Open       Date:  2016-05-18       Impact factor: 2.692

8.  Cultural Differences and Considerations When Initiating Insulin.

Authors:  Julio A Rebolledo; Regina Arellano
Journal:  Diabetes Spectr       Date:  2016-08

9.  Recent trends in vision impairment certifications in England and Wales.

Authors:  Farzana Rahman; Antra Zekite; Catey Bunce; Hari Jayaram; Declan Flanagan
Journal:  Eye (Lond)       Date:  2020-04-14       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.